From Frontiers Forum:
How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO Mehmood Khan, Logitech CEO Bracken Darrell and EPFL’s Henry Markram discussed innovation, R&D and successful technology transfer.
Stefan von Holtzbrinck, Holtzbrinck Publishing Group
Stefan von Holtzbrinck is CEO of the family-owned Holtzbrinck Publishing Group. He has 20 years’ experience in science communication, including 3 years as MD of Nature Publishing Group. The Holtzbrinck Publishing Group has majority holdings in Springer Nature (of which Stefan is Chairman of the Supervisory Board), Digital Science, DIE ZEIT and Macmillan, and investments in Holtzbrinck Ventures, Frontiers, AMBOSS, GSV AcceleraTE and Rethink Education fund. Stefan is a member of the Executive Committee of the Max Planck Society.
Mehmood Khan, Life Biosciences
Mehmood Khan is CEO and Board Member of Life Biosciences Inc, where he provides strategic direction and operational oversight. He was previously Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo and President of Global R&D at Takeda Pharmaceuticals. Before moving into industry, Mehmood had a distinguished medical career, including as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit.
Bracken Darrell, Logitech
Bracken Darrell is President and CEO of Logitech, the largest Swiss consumer electronics company with CHF 3 billion in annual revenues. He is responsible for the company’s strategy for growth and profitability, for the vision for the brand as well as for the company’s operations. Logitech has been a top performer on both the Nasdaq and Swiss stock exchanges. The company value has risen by over 500 percent in the past seven years as the company has moved from PC peripherals to new categories and new brands.
Henry Markram, EPFL
Henry Markram has pioneered simulation neuroscience as a new path to understanding how the brain works. As Professor of Neuroscience at the Swiss Federal Institute of Technology in Lausanne (EPFL), he founded the Brain Mind Institute, the Blue Brain Project and the Human Brain Project, a €1 Billion European initiative to simulate the brain. His research has shifted from experimentally reverse engineering neocortical tissue to developing a software ecosystem and algorithms to convert biological data into detailed digital reconstructions of brain tissue.
Image Credit: Amanda Scott – Alias Studio Sydney
News This Week
Scientists Have Discovered Toxic “Forever Chemicals” in Bottled Water
Scientists have found toxic PFAS in drinking water samples from around the world, with higher levels in tap water from China compared to the UK. Boiling water or using a filtration jug can reduce [...]
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the [...]
Revolutionary Nanoparticle Therapy for Prostate Cancer
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and [...]
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Leave A Comment